GPSM1 impairs metabolic homeostasis by controlling a pro-inflammatory pathway in macrophages (2024)

1. Jing Yan
2. Yuemei Zhang
3. Hairong Yu
4. Yicen Zong
5. Daixi Wang
6. Jiangfei Zheng
7. Li Jin
8. Xiangtian Yu
9. Caizhi Liu
10. Yi Zhang
11. Feng Jiang
12. Rong Zhang
13. Xiangnan Fang
14. Ting Xu
15. Mingyu Li
16. Jianzhong Di
17. Yan Lu
18. Xinran Ma
19. Jian Zhang
20. Weiping Jia
21. Cheng Hu

1. De Vries, L. et al. Activator of G protein signaling 3 is a guanine dissociation inhibitor for Galpha i subunits. Proc. Natl. Acad. Sci. USA 97, 14364–14369 (2000).
   https://doi.org/10.1073/pnas.97.26.14364
2. Pattingre, S. et al. The G-protein regulator AGS3 controls an early event during macroautophagy in human intestinal HT-29 cells. J. Biol. Chem. 278, 20995–21002 (2003).
   https://doi.org/10.1074/jbc.M300917200
3. Pizzinat, N., Takesono, A. & Lanier, S. M. Identification of a truncated form of the G-protein regulator AGS3 in heart that lacks the tetratricopeptide repeat domains. J. Biol. Chem. 276, 16601–16610 (2001).
   https://doi.org/10.1074/jbc.M007573200
4. Flannick, J. et al. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 570, 71–76 (2019).
   https://doi.org/10.1038/s41586-019-1231-2
5. Spracklen, C. N. et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature 582, 240–245 (2020).
   https://doi.org/10.1038/s41586-020-2263-3
6. Vujkovic, M. et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat. Genet. 52, 680–691 (2020).
   https://doi.org/10.1038/s41588-020-0637-y
7. Singh, V., Raghuwanshi, S. K., Smith, N., Rivers, E. J. & Richardson, R. M. G Protein-coupled receptor kinase-6 interacts with activator of G protein signaling-3 to regulate CXCR2-mediated cellular functions. J. Immunol. 192, 2186–2194 (2014).
   https://doi.org/10.4049/jimmunol.1301875
8. Branham-O’Connor, M. et al. Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3). J. Biol. Chem. 289, 10738–10747 (2014).
   https://doi.org/10.1074/jbc.M113.515031
9. Kehrl, J. H. The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity. Biochem. Pharmacol. 114, 40–52 (2016).
   https://doi.org/10.1016/j.bcp.2016.04.005
10. Vural, A. et al. Activator of G-protein signaling 3-induced lysosomal biogenesis limits macrophage intracellular bacterial infection. J. Immunol. 196, 846–856 (2016).
    https://doi.org/10.4049/jimmunol.1501595
11. Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177–185 (2017).
    https://doi.org/10.1038/nature21363
12. Lee, Y. S., Wollam, J. & Olefsky, J. M. An integrated view of immunometabolism. Cell 172, 22–40 (2018).
    https://doi.org/10.1016/j.cell.2017.12.025
13. McNelis, J. C. & Olefsky, J. M. Macrophages, immunity, and metabolic disease. Immunity 41, 36–48 (2014).
    https://doi.org/10.1016/j.immuni.2014.05.010
14. Greenberg, A. S. & Reeves, A. R. The good and bad of adipose tissue macrophage exosomes in obesity. Cell Metab. 33, 700–702 (2021).
    https://doi.org/10.1016/j.cmet.2021.03.011
15. Biswas, S. K. & Mantovani, A. Orchestration of metabolism by macrophages. Cell Metab. 15, 432–437 (2012).
    https://doi.org/10.1016/j.cmet.2011.11.013
16. Chawla, A., Nguyen, K. D. & Goh, Y. P. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738–749 (2011).
    https://doi.org/10.1038/nri3071
17. Nguyen, K. D. et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104–108 (2011).
    https://doi.org/10.1038/nature10653
18. Shan, B. et al. The metabolic ER stress sensor IRE1α suppresses alternative activation of macrophages and impairs energy expenditure in obesity. Nat. Immunol. 18, 519–529 (2017).
    https://doi.org/10.1038/ni.3709
19. Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656–661 (2010).
    https://doi.org/10.1126/science.1178331
20. Yvan-Charvet, L. et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328, 1689–1693 (2010).
    https://doi.org/10.1126/science.1189731
21. Tang, C. et al. Hematopoietic ABCA1 deletion promotes monocytosis and worsens diet-induced insulin resistance in mice. J. Lipid Res. 57, 100–108 (2016).
    https://doi.org/10.1194/jlr.M064303
22. Marcelin, G., Silveira, A. L. M., Martins, L. B., Ferreira, A. V. & Clément, K. Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis. J. Clin. Investig. 129, 4032–4040 (2019).
    https://doi.org/10.1172/JCI129192
23. Tanaka, M. et al. Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis. Nat. Commun. 5, 4982 (2014).
    https://doi.org/10.1038/ncomms5982
24. Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 127, 1–4 (2017).
    https://doi.org/10.1172/JCI92035
25. Wu, H. & Ballantyne, C. M. Metabolic inflammation and insulin resistance in obesity. Circ. Res. 126, 1549–1564 (2020).
    https://doi.org/10.1161/CIRCRESAHA.119.315896
26. Keiran, N. et al. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity. Nat. Immunol. 20, 581–592 (2019).
    https://doi.org/10.1038/s41590-019-0372-7
27. Abram, C. L., Roberge, G. L., Hu, Y. & Lowell, C. A. Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice. J. Immunol. Methods 408, 89–100 (2014).
    https://doi.org/10.1016/j.jim.2014.05.009
28. Yao, J. et al. Macrophage IRX3 promotes diet-induced obesity and metabolic inflammation. Nat. Immunol. 22, 1268–1279 (2021).
    https://doi.org/10.1038/s41590-021-01023-y
29. Bijnen, M. et al. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. Gut 67, 1317–1327 (2018).
    https://doi.org/10.1136/gutjnl-2016-313654
30. Aratani, Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch. Biochem. Biophys. 640, 47–52 (2018).
    https://doi.org/10.1016/j.abb.2018.01.004
31. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772 (2007).
    https://doi.org/10.2337/db06-1491
32. Baker, R. G., Hayden, M. S. & Ghosh, S. NF-κB, inflammation, and metabolic disease. Cell Metab. 13, 11–22 (2011).
    https://doi.org/10.1016/j.cmet.2010.12.008
33. Hayden, M. S. & Ghosh, S. Shared principles in NF-kappaB signaling. Cell 132, 344–362 (2008).
    https://doi.org/10.1016/j.cell.2008.01.020
34. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Investig. 116, 3015–3025 (2006).
    https://doi.org/10.1172/JCI28898
35. Wang, X. et al. Macrophage-specific hypoxia-inducible factor-1α contributes to impaired autophagic flux in nonalcoholic steatohepatitis. Hepatology 69, 545–563 (2019).
    https://doi.org/10.1002/hep.30215
36. Conley, J. M. & Watts, V. J. Differential effects of AGS3 expression on D(2L) dopamine receptor-mediated adenylyl cyclase signaling. Cell. Mol. Neurobiol. 33, 551–558 (2013).
    https://doi.org/10.1007/s10571-013-9925-8
37. Yao, L. et al. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc. Natl. Acad. Sci. USA 102, 8746–8751 (2005).
    https://doi.org/10.1073/pnas.0503419102
38. Shaywitz, A. J. & Greenberg, M. E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821–861 (1999).
    https://doi.org/10.1146/annurev.biochem.68.1.821
39. Kriebs, A. Adipocyte to macrophage mitochondria transfer. Nat. Rev. Endocrinol. 17, 132 (2021).
    https://doi.org/10.1038/s41574-020-00463-0
40. Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
    https://doi.org/10.1038/s41586-021-03819-2
41. Tunyasuvunakool, K. et al. Highly accurate protein structure prediction for the human proteome. Nature 596, 590–596 (2021).
    https://doi.org/10.1038/s41586-021-03828-1
42. Song, K. et al. Improved Method for the Identification and Validation of Allosteric Sites. J. Chem. Inf. Modeling 57, 2358–2363 (2017).
    https://doi.org/10.1021/acs.jcim.7b00014
43. Zhao, G. N. et al. TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease. Cell Metab. 33, 1640–1654.e1648 (2021).
    https://doi.org/10.1016/j.cmet.2021.05.014
44. Slawik, M. & Vidal-Puig, A. J. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res. Rev. 5, 144–164 (2006).
    https://doi.org/10.1016/j.arr.2006.03.004
45. Turer, A. T., Hill, J. A., Elmquist, J. K. & Scherer, P. E. Adipose tissue biology and cardiomyopathy: translational implications. Circ. Res. 111, 1565–1577 (2012).
    https://doi.org/10.1161/CIRCRESAHA.111.262493
46. Morigny, P., Boucher, J., Arner, P. & Langin, D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat. Rev. Endocrinol. 17, 276–295 (2021).
    https://doi.org/10.1038/s41574-021-00471-8
47. Senol-Cosar, O. et al. Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion. Nat. Commun. 7, 10686 (2016).
    https://doi.org/10.1038/ncomms10686
48. Shao, M. et al. De novo adipocyte differentiation from Pdgfrβ(+) preadipocytes protects against pathologic visceral adipose expansion in obesity. Nat. Commun. 9, 890 (2018).
    https://doi.org/10.1038/s41467-018-03196-x
49. Blumer, J. B. et al. Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function. Endocrinology 149, 3842–3849 (2008).
    https://doi.org/10.1210/en.2008-0050
50. Bowers, M. S. et al. AGS3: a G-Protein regulator of addiction-associated behaviors. Ann. N. Y. Acad. Sci. 1003, 356–357 (2003).
    https://doi.org/10.1196/annals.1300.025
51. Wang, W. et al. Increased expression of AGS3 in rat brain cortex after traumatic brain injury. J. Neurosci. Res. 91, 726–736 (2013).
    https://doi.org/10.1002/jnr.23195
52. Ben, J. et al. Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation. Nat. Commun. 10, 1801 (2019).
    https://doi.org/10.1038/s41467-019-09588-x
53. Boone, D. L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052–1060 (2004).
    https://doi.org/10.1038/ni1110
54. Liu, S. S. et al. Targeting degradation of the transcription factor C/EBPβ reduces lung fibrosis by restoring activity of the ubiquitin-editing enzyme A20 in macrophages. Immunity 51, 522–534.e527 (2019).
    https://doi.org/10.1016/j.immuni.2019.06.014
55. Ouyang, X. et al. Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1α pathway. Nat. Commun. 4, 2909 (2013).
    https://doi.org/10.1038/ncomms3909
56. Zoccal, K. F. et al. Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality. Nat. Commun. 7, 10760 (2016).
    https://doi.org/10.1038/ncomms10760
57. Yoon, Y. S. et al. cAMP-inducible coactivator CRTC3 attenuates brown adipose tissue thermogenesis. Proc. Natl. Acad. Sci. USA 115, E5289–e5297 (2018).
    https://doi.org/10.1073/pnas.1805257115
58. Tabas, I. & Glass, C. K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339, 166–172 (2013).
    https://doi.org/10.1126/science.1230720
59. Esser, N., Paquot, N. & Scheen, A. J. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome, and cardiovascular disease. Expert Opin. Invest. Drugs 24, 283–307 (2015).
    https://doi.org/10.1517/13543784.2015.974804
60. Devuyst, O. & Rippe, B. Water transport across the peritoneal membrane. Kidney Int. 85, 750–758 (2014).
    https://doi.org/10.1038/ki.2013.250
61. Mills, E. L. et al. Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation. Cell Metab. 34, 140–157.e148 (2022).
    https://doi.org/10.1016/j.cmet.2021.11.003
62. Davis, K. E. et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol. Metab. 2, 227–242 (2013).
    https://doi.org/10.1016/j.molmet.2013.05.006
63. Shao, M. et al. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling. Nat. Commun. 5, 3528 (2014).
    https://doi.org/10.1038/ncomms4528
64. Ahn, Y.J., Wang, L. & Asmis, R. Quantification of monocyte chemotactic activity in vivo and characterization of blood monocyte derived macrophages. J. Vis. Exp.: JoVE https://doi.org/10.3791/59706 (2019).
    https://doi.org/10.3791/59706
65. Ahn, Y. J. et al. Glutaredoxin 1 controls monocyte reprogramming during nutrient stress and protects mice against obesity and atherosclerosis in a sex-specific manner. Nat. Commun. 13, 790 (2022).
    https://doi.org/10.1038/s41467-022-28433-2
66. Shoichet, B. K., McGovern, S. L., Wei, B. & Irwin, J. J. Lead discovery using molecular docking. Curr. Opin. Chem. Biol. 6, 439–446 (2002).
    https://doi.org/10.1016/S1367-5931(02)00339-3

Properties of biomolecular condensates defined by Activator of G-protein Signaling 3

Ali Vural, Stephen M. Lanier

https://doi.org/10.1242/jcs.261326 ·

Excess body weight: Novel insights into its roles in obesity comorbidities

Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau, Jun Yu

https://doi.org/10.1016/j.semcancer.2023.03.008

SARS-CoV-2 superinfection in CD14+ monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade

Shannon Harger Payen, Kabita Adhikari, Juli Petereit, Timsy Uppal, Cyprian C. Rossetto, Subhash C. Verma

https://doi.org/10.1016/j.virusres.2024.199375

Adipocyte-Specific <i>Hnrnpa1</i> Knockout Aggravates Obesity-Induced Metabolic Dysfunction via Upregulation of CCL2

Xiaoya Li, Yingying Su, Yiting Xu, Tingting Hu, Xuhong Lu, Jingjing Sun, Wenfei Li, Jian Zhou, Xiaojing Ma, Ying Yang, Yuqian Bao

https://doi.org/10.2337/db23-0609 ·

Identification of ibuprofen targeting CXCR family members to alleviate metabolic disturbance in lipodystrophy based on bioinformatics and in vivo experimental verification

Zhiwen Cao, Yuxiao Zhao, Ruixin Liu, Xialin Yan, Jiqiu Wang, Na Chen

https://doi.org/10.3389/fendo.2024.1414908 ·

About this publication